Cross-Sector entity

PharmEasy

Company
6

Of the tracked stories, 3 of 3 also mention All Home, the most common co-covered peer. The clearest coverage concentration is consumer-trends: 1 of 3 stories, with the rest divided among 2 other categories. The tracked stories average 2 original sources each.

3 verified stories tracked

Last mentioned: Jun 27, 2026

Entity pulse

Recent coverage · PharmEasy

3 stories
6 avg impact
100% positive
0% negative

Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.

  • 100% positive

Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.

What the coverage shows about PharmEasy

Of the tracked stories, 3 of 3 also mention All Home, the most common co-covered peer. The clearest coverage concentration is consumer-trends: 1 of 3 stories, with the rest divided among 2 other categories. The tracked stories average 2 original sources each. PharmEasy appears in 3 tracked Cross-Sector stories from June 27, 2026.

Stories tracked
3
Sources per story
2

Computed from the 3 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.

Coverage cohort

Appears alongside

Other entities that clear the same relevance threshold in stories also covering PharmEasy. Shared-story counts are live from our verified record — not editorial picks.

Timeline

  1. Series A Funding Round

    All Home raises Rs 200 crore in equity and debt, doubling valuation to Rs 2,000 crore. Led by Bessemer Venture Partners with debt from Stride Ventures.

  2. Seed Funding Round

    All Home raises $20 million (~Rs 180 crore) at a valuation of around Rs 1,000 crore.

Stories mentioning PharmEasy 3